NCT00401271View on ClinicalTrials.gov

Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

March 31, 2007

Conditions
Pulmonary Tuberculosis
Interventions
DRUG

OPC-67683

DRUG

Rifafour e-275

Trial Locations (3)

4000

Medical Research Council, Durban

7531

Tiervlei Trial Center, Karl Bremer Hospital, Bellville

7700

University of Cape Town Lung Institute, Mowbray

All Listed Sponsors
lead

Otsuka Frankfurt Research Institute GmbH

INDUSTRY

NCT00401271 - Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis | Biotech Hunter | Biotech Hunter